BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37922005)

  • 21. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL.
    Stein SJ; Mack EA; Rome KS; Pajcini KV; Ohtani T; Xu L; Li Y; Meijerink JP; Faryabi RB; Pear WS
    PLoS One; 2016; 11(5):e0155408. PubMed ID: 27191957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
    Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crucial role of the Rap G protein signal in Notch activation and leukemogenicity of T-cell acute lymphoblastic leukemia.
    Doi K; Imai T; Kressler C; Yagita H; Agata Y; Vooijs M; Hamazaki Y; Inoue J; Minato N
    Sci Rep; 2015 Jan; 5():7978. PubMed ID: 25613394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch pathway activation induces neuroblastoma tumor cell growth arrest.
    Zage PE; Nolo R; Fang W; Stewart J; Garcia-Manero G; Zweidler-McKay PA
    Pediatr Blood Cancer; 2012 May; 58(5):682-9. PubMed ID: 21744479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells.
    Nwabo Kamdje AH; Mosna F; Bifari F; Lisi V; Bassi G; Malpeli G; Ricciardi M; Perbellini O; Scupoli MT; Pizzolo G; Krampera M
    Blood; 2011 Jul; 118(2):380-9. PubMed ID: 21602525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.
    Tsaouli G; Ferretti E; Bellavia D; Vacca A; Felli MP
    J Immunol Res; 2019; 2019():5601396. PubMed ID: 31346528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential WNT gene expression in various subtypes of acute lymphoblastic leukemia.
    Memarian A; Vosough P; Asgarian-Omran H; Tabrizi M; Shabani M; Shokri F
    Iran J Immunol; 2012 Mar; 9(1):61-71. PubMed ID: 22426169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
    Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL.
    Pelullo M; Quaranta R; Talora C; Checquolo S; Cialfi S; Felli MP; te Kronnie G; Borga C; Besharat ZM; Palermo R; Di Marcotullio L; Capobianco AJ; Gulino A; Screpanti I; Bellavia D
    Neoplasia; 2014 Dec; 16(12):1007-17. PubMed ID: 25499214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Mechanisms of Drug Resistance in Leukemia.
    Knoechel B; Aster JC
    Cell Metab; 2015 Nov; 22(5):759-60. PubMed ID: 26536486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
    Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
    Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nuclear pore proteins Nup88/214 and T-cell acute lymphatic leukemia-associated NUP214 fusion proteins regulate Notch signaling.
    Kindermann B; Valkova C; Krämer A; Perner B; Engelmann C; Behrendt L; Kritsch D; Jungnickel B; Kehlenbach RH; Oswald F; Englert C; Kaether C
    J Biol Chem; 2019 Aug; 294(31):11741-11750. PubMed ID: 31186352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells.
    Zampieri M; Ciccarone F; Palermo R; Cialfi S; Passananti C; Chiaretti S; Nocchia D; Talora C; Screpanti I; Caiafa P
    Biochim Biophys Acta; 2014 Sep; 1839(9):813-25. PubMed ID: 24984200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-driven activation of the notch pathway in T-ALL and solid tumors: why Not(ch)?
    Indraccolo S; Minuzzo S; Masiero M; Amadori A
    Cell Cycle; 2010 Jan; 9(1):80-5. PubMed ID: 20016278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of Notch3 Using shRNA driven by survivin promoter inhibits growth and promotes apoptosis of human T-cell acute lymphoblastic leukemia cells.
    Xiang J; Ouyang Y; Cui Y; Lin F; Ren J; Long M; Chen X; Wei J; Zhang H
    Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):59-65. PubMed ID: 21940234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
    Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
    PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.